Popular
Latest Articles
PEPR-124 (RT001): An AI-Discovered, Mutation-Agnostic Drug Candidate for Duchenne Muscular Dystrophy
PEPR-124 (also designated as RT001) is an AI-discovered drug...
RyCarma’s Surlorian (ARM 210) Advances Toward Duchenne Muscular Dystrophy Research
RyCarma Therapeutics is developing Surlorian (ARM 210), an experimental...
7 Breakthrough DMD Research Programs That Could Transform Duchenne Treatment in 2027
Duchenne muscular dystrophy (DMD) research continues to advance, opening...
Most Popular
Frequently Asked Questions About Elevidys Used for DMD
Duchenne muscular dystrophy (DMD) is a genetic condition that...
Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy
The landscape of potential new gene therapies for Duchenne...
The Brutal Truth: Why Duchenne Muscular Dystrophy Treatment Costs Are Out of Control
The duchenne muscular dystrophy treatment cost has become one...
© 2024 - 2026 DMD Warrior. All rights reserved.